HIV-1 envelope glycoprotein amino acids signatures associated with clade B transmitted/founder and recent viruses
dc.contributor.author | Kafando, Alexis | |
dc.contributor.author | Martineau, Christine | |
dc.contributor.author | El-Far, Mohamed | |
dc.contributor.author | Fournier, Eric | |
dc.contributor.author | Doualla-Bell, Florence | |
dc.contributor.author | Serhir, Bouchra | |
dc.contributor.author | Kazienga, Adama | |
dc.contributor.author | Sangaré, Mohamed Ndongo | |
dc.contributor.author | Sylla, Mohamed | |
dc.contributor.author | Chamberland, Annie | |
dc.contributor.author | Charest, Hugues | |
dc.contributor.author | Tremblay, Cécile | |
dc.date.accessioned | 2020-02-04T20:14:00Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2020-02-04T20:14:00Z | |
dc.date.issued | 2019-11-01 | |
dc.identifier.uri | http://hdl.handle.net/1866/23061 | |
dc.publisher | MDPI | fr |
dc.subject | HIV-1 | fr |
dc.subject | Acute/early infection | fr |
dc.subject | Transmitted/founder viruses | fr |
dc.subject | Recent viruses | fr |
dc.subject | Envelope | fr |
dc.subject | Amino acids | fr |
dc.subject | Genetic signatures | fr |
dc.subject | Signal peptide | fr |
dc.subject | Cytoplasmic domain | fr |
dc.subject | Lentivirus lytic peptide segment 1 | fr |
dc.title | HIV-1 envelope glycoprotein amino acids signatures associated with clade B transmitted/founder and recent viruses | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de microbiologie, infectiologie et immunologie | fr |
dc.identifier.doi | 10.3390/v11111012 | |
dcterms.abstract | Background: HIV-1 transmitted/founder viruses (TF) are selected during the acute phase of infection from a multitude of virions present during transmission. They possess the capacity to establish infection and viral dissemination in a new host. Deciphering the discrete genetic determinant of infectivity in their envelope may provide clues for vaccine design. Methods: One hundred twenty-six clade B HIV-1 consensus envelope sequences from untreated acute and early infected individuals were compared to 105 sequences obtained from chronically infected individuals using next generation sequencing and molecular analyses. Results: We identified an envelope amino acid signature associated with TF viruses. They are more likely to have an isoleucine (I) in position 841 instead of an arginine (R). This mutation of R to I (R841I) in the gp41 cytoplasmic tail (gp41CT), specifically in lentivirus lytic peptides segment 1 (LLP-1), is significantly enriched compared to chronic viruses (OR = 0.2, 95% CI (0.09, 0.44), p = 0.00001). Conversely, a mutation of lysine (K) to isoleucine (I) located in position six (K6I) of the envelope signal peptide was selected by chronic viruses and compared to TF (OR = 3.26, 95% CI (1.76–6.02), p = 0.0001). Conclusions: The highly conserved gp41 CT_ LLP-1 domain plays a major role in virus replication in mediating intracellular traffic and Env incorporation into virions in interacting with encoded matrix protein. The presence of an isoleucine in gp41 in the TF viruses’ envelope may sustain its role in the successful establishment of infection during the acute stage. | fr |
dcterms.isPartOf | urn:ISSN:1999-4915 | fr |
dcterms.isPartOf | urn:ISSN:1999-4915 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | Viruses 2019, 11, 1012; doi:10.3390/v11111012 | fr |
UdeM.VersionRioxx | Version publiée / Version of Record | fr |
oaire.citationTitle | Viruses | |
oaire.citationVolume | 11 | |
oaire.citationIssue | 1012 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.